anonymous
Guest
anonymous
Guest
Has anyone heard that the sublingual apomorphine PDUFA might be pushed because of the coronovirus pandemic?
Or that we might hold the launch until the pandemic passes and field force can have face to face interactions with doctors?
Brand Team is worry, Tony is worry.
The demand may be really really low considering the poor sales of the competitor Acorda Inbrijia.
Good possibility that Field Force numbers will be cut if the lockdowns continue.
Or that we might hold the launch until the pandemic passes and field force can have face to face interactions with doctors?
Brand Team is worry, Tony is worry.
The demand may be really really low considering the poor sales of the competitor Acorda Inbrijia.
Good possibility that Field Force numbers will be cut if the lockdowns continue.